Home · Peptides · IGF-LR3
THE PEPTIDE APP FIELD GUIDE · Metabolic SERIES FIELD SPECIMEN
Metabolic CATEGORY

IGF-LR3

THE MUSCLE MAXIMIZER

Long R3 Insulin-like Growth Factor-1; LR3 IGF-1

IGF-LR3 is a modified version of IGF-1 with a much longer half-life. The modifications make it more potent and longer-lasting than natural IGF-1. It activates muscle satellite cells, promotes protein synthesis, and has powerful anabolic effects, which makes it popular among bodybuilders and those seeking muscle growth.

IGF-LR3
IGF-LR3
IGF-LR3

IGF-LR3 Evidence Snapshot

How these guides are reviewed
REGULATORY STATUS

Not FDA approved · research use only

DOSING GUIDANCE

Reviewed by our clinical team

LINKED EVIDENCE

1 research sources

CONTENT UPDATED

Aug 28, 2026

Dose and schedule recommendations shown below come from The Peptide App Clinical Team. Research links are provided so readers can inspect the supporting evidence directly. Review the sources.

Quick Answers About IGF-LR3

◆

Is IGF-LR3 FDA approved?

No. This profile records IGF-LR3 as not FDA approved and for research use only.

MORE CONTEXT ›

Review the regulatory and source details on this page for the current context.

◆

What dose does The Peptide App Clinical Team recommend for IGF-LR3?

Dose: 20-50 mcg daily.

MORE CONTEXT ›

Schedule: daily. Cycle: 4-6 weeks on, 4 weeks off. This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.

◆

What research supports this IGF-LR3 guide?

This guide links to 1 curated or current research sources.

MORE CONTEXT ›

Open the research section to inspect the source titles, publication details, study types, and available abstracts directly.

Studied Effects & Mechanisms

IGF-1 Receptor Activation

Strongly activates IGF-1 receptors for growth signaling

Muscle Growth

Stimulates protein synthesis and satellite cell activation

Extended Half-Life

Modified structure resists binding proteins, lasting much longer

Bodybuilders seeking muscle growth
Athletes wanting enhanced recovery
Those with muscle-wasting conditions
People wanting fat loss with muscle preservation

IGF-LR3 Research

Live research temporarily unavailable

The live research feed did not return papers for this page. The curated references below remain available for crawlable source context.

RESEARCH REFERENCES